AGM Statement

RNS Number:1136B
Celsis International PLC
22 July 2004



Celsis International plc

AGM Statement

Celsis International plc, a leading international manufacturer of rapid
diagnostic testing systems for the world's pharmaceutical, personal care, dairy
and beverage industries (the Product Group) and a leading US supplier of cGMP
analytical services for the pharmaceutical industry (the Laboratory Group) held
its Annual General Meeting today at which all resolutions were duly passed.


Commenting on trading in the current year, Dr Jack Rowell, Chairman, made the
following statement:


"In the report and accounts for the year ended 31 March 2004, we announced that
Celsis had achieved another successful year, reporting a 22.5% increase in
profitability. As a result of this and our future confidence for the business, I
am pleased to confirm the payment of our first dividend of 0.86 cents per share.
The dividend will be paid on the 28 August 2004 to holders of Celsis shares
registered on the 30 July 2004.


"The year has started well.  Our excellent performance in the pharmaceutical and
personal care sectors has continued into the current period as we maintain focus
on our Global Corporate Account Management (GCAM) customers to expand our
installed base.   We also remain committed to providing these customers with
leading edge microbial detection systems, as has been demonstrated with the
Celsis AKuScreenTM testing system.


"In addition, I am encouraged by our continuing inroads in the dairy sector
following our launch last year of the new CellScan InnovateTM rapid testing
system specifically designed for this industry.  The Innovate system has already
captured a number of worldwide dairy customers, because of its enhanced
detection capabilities.  We expect to see solid growth in this business area
this year as CellScan InnovateTM establishes itself as the new industry
standard.


"The last quarter of last year a robust improvement in revenues from the
Laboratory Group which shows every sign of continuing into this year.  Although
still early days, we are confident that the Laboratory Group is poised to expand
on its solid business fundamentals.


"The Group is in excellent shape both financially and operationally.  Celsis has
carved a leadership role in its niche segment with its system integrated into
the manufacturing process of a range of blue chip companies around the world.
Our marketplace and potential customer base remains huge however and presents a
considerable opportunity for Celsis and its shareholders in the coming year and
beyond."

                                                                    22 July 2004

Enquiries:

Celsis International plc                                      Tel: [phone]
Jay LeCoque, Chief Executive Officer
Jenny Parsons, Corporate Communications

College Hill                                                  Tel: [phone]
Nicholas Nelson / Corinna Dorward


Notes to editors


Celsis International plc

Celsis International plc is a world leader in the development and supply of
rapid diagnostic and monitoring systems to detect and measure microbial
contamination in finished products bound for consumers.  It has successfully
developed tests for use in the pharmaceutical, cosmetic and toiletries, food,
beverage and dairy industries.  These tests are based upon years of research in
enzyme technology that employ numerous methods for the rapid detection of
microbial contamination.  Celsis International plc also has a leading laboratory
services company servicing the pharmaceutical and cosmetic and toiletries
industries, which operates primarily in the United States.


For further information on Celsis International plc visit www.celsis.com



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

AGMSEIFSESLSEDW